IM Cannabis (IMCC) Free Cash Flow (2020 - 2026)
IM Cannabis' (IMCC) quarterly Free Cash Flow came in at -$131986.2 in Q1 2026, down 104.24% year-on-year from $3.1 million in Q1 2025, and down 104.38% quarter-over-quarter from $3.0 million in Q4 2025.
IM Cannabis (IMCC) Free Cash Flow (2020 - 2026) Analysis & Trends
IM Cannabis' Free Cash Flow history runs 7 years deep, the most recent figure standing at -$131986.2 for Q1 2026.
- On a quarterly basis, Free Cash Flow fell 104.24% year-over-year to -$131986.2 in Q1 2026; TTM through Mar 2026 was $1690.1, a 99.94% decrease from a year earlier, with the FY2025 full-year figure at $3.4 million, up 474.48% from the prior year.
- Free Cash Flow declined to -$131986.2 in Q1 2026 per IMCC's latest filing, from $3.0 million in the prior quarter.
- Across five years, Free Cash Flow topped out at $4.0 million in Q3 2023 and bottomed at -$6.9 million in Q1 2022.
- The 5-year median for Free Cash Flow is -$465305.0 (2024), against an average of -$750602.8.
- Across the five-year window, Free Cash Flow slumped 508.65% in 2023 and soared 768.45% in 2025, its largest moves.
- Year by year, Free Cash Flow stood at -$1.7 million in 2022, then jumped by 42.42% to -$993092.0 in 2023, then slumped by 223.0% to -$3.2 million in 2024, then surged by 193.98% to $3.0 million in 2025, then tumbled by 104.38% to -$131986.2 in 2026.
- Per Business Quant, the three latest IMCC Free Cash Flow figures stand at -$131986.2 (Q1 2026), $3.0 million (Q4 2025), and -$2.5 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -208.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 291.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -373.37 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 363.70 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 348.40 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 144.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -38.00 Mn |
| 10 | IM Cannabis | 591,792.44 | -193,562.09 | 1.03 Mn | -131,986.23 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -131,986.23 |
| Mar 31, 2026 | -131,986.23 |
| Dec 31, 2025 | 3.01 Mn |
| Dec 31, 2025 | 3.01 Mn |
| Sep 30, 2025 | -2.54 Mn |
| Sep 30, 2025 | -2.54 Mn |
| Jun 30, 2025 | -342,091.72 |
| Jun 30, 2025 | -342,091.72 |
| Mar 31, 2025 | 3.11 Mn |
| Mar 31, 2025 | 3.11 Mn |
| Dec 31, 2024 | -3.21 Mn |
| Dec 31, 2024 | -3.21 Mn |
| Sep 30, 2024 | 2.07 Mn |
| Sep 30, 2024 | 2.07 Mn |
| Jun 30, 2024 | 765,504.15 |
| Jun 30, 2024 | 765,504.15 |
| Mar 31, 2024 | -465,304.98 |
| Mar 31, 2024 | -465,304.98 |
| Dec 31, 2023 | -993,092.03 |
| Dec 31, 2023 | -993,092.03 |